With the rise of the fourth industrial revolution—Industry 4.0—technology has become an inextricable aspect of business operations in most sectors. RFID (Radio Frequency Identification) has become ubiquitous across a wide range of industries. Its emergence in the pharmaceutical industry is mainly attributed to the high importance of safety and security of business operations. With growing consumer awareness about the toxic counterfeit products pushed in the market, the technology is likely to discern exponential growth in the industry.
Being one of the most supervised and sensitive product groups, pharmaceuticals are subjected to numerous safety norms, and manufacturers have to ensure the drug quality and adhere to stringent regulations. In addition, increasing risks from substandard and falsified drugs are creating a need for efficient anti-counterfeiting solutions in the pharmaceutical industry. This has boosted the adoption of RFID in combination with the electronic product code (EPC) in the industry.